1 unknown, 1 withdrawn. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Triacetin: new trials by email Literature Review of Triacetin trials Research Report on Triacetin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lithium and Acetate for Canavan Disease Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug) - Canavan Disease, Infantile | Phase 2 | Withdrawn | Assistance Publique - Hôpitaux de Paris | 2009-09-01 | 2015-04-21 | |
| Oral Glyceryl Triacetate (GTA) in Newborns With Canavan GTA (Glyceryl triacetate), GTA glyceryl triacetate - Canavan Disease | Not applicable | Unknown | Shaare Zedek Medical Center | 1 | 2008-03-01 | 2011-06-21 |
Canavan Disease (2) · Deficiency Diseases (1)
Assistance Publique - Hôpitaux de Paris (1) · Shaare Zedek Medical Center (1)
Israel (1)
Caroline Sevin, MD, PhD (1) · Gheona Alterescu, M.D. (1) · Patrick Aubourg, MD, PhD (1)
PMID 12064356, PMID 15784740, PMID 16002461, PMID 16194720, PMID 21474353